EUVIMEDEUVIMED entdecken
Crossref

Brain–computer interfaces and neuromodulation in neurodegenerative disorders: What constitutes clinical benefit?

Hui Huang, Chao Wang, Liming Zhang, Kenji Karako

Intractable & Rare Diseases Research · 2026

DOI: 10.5582/irdr.2026.01076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Intractable & Rare Diseases Research, 2026. Verfasst von Hui Huang und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in neural recording and stimulation are creating opportunities to aid everyday functioning in people with neurodegenerative disorders. This Perspective examines how the clinical value of brain–computer interfaces and neuromodulation should be judged across interventions with different therapeutic goals and levels of evidence. Parkinson's disease, amyotrophic lateral sclerosis, and Alzheimer's disease provide contrasting settings for motor symptom control, assistive communication, and preservation of cognition. The studies considered range from adaptive stimulation in clinical use and sustained communication in selected individuals to exploratory interventions in cognitive impairment. Clinical evaluation should establish the safety and reliability of these systems and determine whether they improve activities that matter to patients, such as spontaneous conversation or walking without assistance. Follow-up should determine whether these functional benefits are sustained under the conditions of everyday life. Device management, caregiver time, and access to continuing technical and clinical support form part of that assessment, particularly as disability progresses. Claims of disease modification require controlled longitudinal evidence of an altered disease course. Clinical studies should therefore define the intended functional benefit and assess who benefits, for how long, and with what continuing demands on patients, families and health services.

Zitieren

APA

Huang, H., Wang, C., Zhang, L., & Karako, K. (2026). Brain–computer interfaces and neuromodulation in neurodegenerative disorders: What constitutes clinical benefit?. Intractable & Rare Diseases Research. https://doi.org/10.5582/irdr.2026.01076

Vancouver

Huang H, Wang C, Zhang L, Karako K. Brain–computer interfaces and neuromodulation in neurodegenerative disorders: What constitutes clinical benefit?. Intractable & Rare Diseases Research. 2026. doi:10.5582/irdr.2026.01076

BibTeX
@article{Huang2026,
  author = {Huang, Hui and Wang, Chao and Zhang, Liming and Karako, Kenji},
  title = {Brain–computer interfaces and neuromodulation in neurodegenerative disorders: What constitutes clinical benefit?},
  journal = {Intractable & Rare Diseases Research},
  year = {2026},
  doi = {10.5582/irdr.2026.01076}
}
Kostenlos starten →